News
A New Antibiotic That Defeats Superbugs Just Received FDA Approval for Dangerous Drug-Resistant Urinary Tract Infections
FDA approved Zaynich (cefepime and zidebactam) on May 29, 2026 for complicated urinary tract infections caused by drug-resistant Gram-negative pathogens. ENHANCE-1 Phase 3 trial showed superiority to meropenem at test of cure. Here is how it works and who benefits.
→
First-in-Class Drug Targeting Treatment-Resistant High Blood Pressure Wins FDA Approval — and Works Like No Existing Drug
FDA approved baxdrostat (Baxfendy) on May 18, 2026 as the first-ever oral aldosterone synthase inhibitor for uncontrolled and resistant hypertension. BaxHTN Phase 3 (NEJM 2025): 8.7–9.8 mmHg additional systolic blood pressure reduction added to background therapy. Here is the full story.
→
A Woman Dies of Plague in New Mexico as Summer Brings Higher Risk of the Ancient Disease Across the American Southwest
The New Mexico Department of Health confirmed the death of a Santa Fe County woman from plague on June 11, 2026 — the state's first human plague fatality this year. Three dogs have tested positive in 2026. About half of all US plague cases occur in New Mexico. Here is the peak season warning.
→
